Posted by Michael Wonder on 04 Feb 2022

Lawmakers grill key FDA official over controversial Alzheimer’s drug approval

3 February 2022 - The FDA can’t escape questions about Aduhelm.

Read Stat News article

Posted by:

Michael Wonder

Posted in:

Medicine , US , Regulation